These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 4225316)
1. A chemical treatment for schizophrenia. Alvarez WC Geriatrics; 1967 Mar; 22(3):111-2. PubMed ID: 4225316 [No Abstract] [Full Text] [Related]
2. Nicotinic acid in the treatment of newly admitted schizophrenic patients: a placebo-controlled study. Ananth JV; Vacaflor L; Kekhwa G; Sterlin C; Ban TA Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):406-10. PubMed ID: 4261601 [No Abstract] [Full Text] [Related]
3. Nicotinic acid in the treatment of chronic hospitalized schizophrenic patients: a placebo-controlled clinical study. Deutsch M; Ananth JV; Ban TA Psychopharmacol Bull; 1977 Jul; 13(3):21-3. PubMed ID: 142260 [No Abstract] [Full Text] [Related]
4. The effect of nicotinic acid on the frequency and duration of re-hospitalization of schizophrenic patients; a controlled comparison study. Hoffer A Int J Neuropsychiatry; 1966 Jun; 2(3):234-40. PubMed ID: 4225426 [No Abstract] [Full Text] [Related]
5. Nicotinic acid and nicotinamide adenine dinucleotide (NAD) therapy in schizophrenia: a review. Wittkopp TA; Abuzzahab FS Behav Neuropsychiatry; 1972; 4(7-8):6-12. PubMed ID: 4348727 [No Abstract] [Full Text] [Related]
6. Biochemistry of nicotinic acid and nicotinamide. Hoffer A Psychosomatics; 1967; 8(2):95-100. PubMed ID: 4227744 [No Abstract] [Full Text] [Related]
7. Use of nicotinic acid and/or nicotinamide in high doses to treat schizophrenia. Hoffer A Can J Psychiatr Nurs; 1966 Oct; 7(8):5-6. PubMed ID: 4224196 [No Abstract] [Full Text] [Related]
8. Nicotinic acid in the treatment of schizophrenia. Med Lett Drugs Ther; 1973 Dec; 15(26):107-8. PubMed ID: 4271841 [No Abstract] [Full Text] [Related]
9. Letter: Dr. Pauling comments on the comments. Pauling L Am J Psychiatry; 1974 Dec; 131(12):1405-6. PubMed ID: 4279560 [No Abstract] [Full Text] [Related]
10. [Biochemical treatment possibilities in psychoses]. Kanig K; Oesterle W Med Welt; 1969 Sep; 36():1938-45. PubMed ID: 4241466 [No Abstract] [Full Text] [Related]
11. Nicotinic acid and nicotinamide in the treatment of chronic schizophrenia. Vallely JF; Lovegrove TD; Hobbs GE Can Psychiatr Assoc J; 1971 Oct; 16(5):433-5. PubMed ID: 4261335 [No Abstract] [Full Text] [Related]
12. Letter: NAD and chronic schizophrenia. Altus MS Am J Psychiatry; 1974 Sep; 131(9):1043-4. PubMed ID: 4370155 [No Abstract] [Full Text] [Related]
14. [Use of nicotinic acid in the treatment of chronic schizophrenia]. Maslowski J Psychiatr Pol; 1967; 1(3):307-11. PubMed ID: 5593258 [No Abstract] [Full Text] [Related]
15. [The role of nicotinic acid and its derivatives in the etiopathogenesis of schizophrenia]. Slowik S Psychiatr Pol; 1969; 3(1):89-95. PubMed ID: 4389305 [No Abstract] [Full Text] [Related]
16. Psychiatric manifestation in pellagra. Shah DR; Pandey SK; Rathi R J Assoc Physicians India; 1972 Aug; 20(8):575-8. PubMed ID: 4680826 [No Abstract] [Full Text] [Related]
17. Nicotinic acid as an adjuvant in the treatment of chronic schizophrenic patients with special reference to changes in higher nervous activity. Saarma J; Vasar H Curr Ther Res Clin Exp; 1970 Nov; 12(11):729-33. PubMed ID: 4993126 [No Abstract] [Full Text] [Related]
18. [Clinical experience with a nicotinic acid derivative in schizophrenia]. Silva AR; Ribeiro I; Sobrinho MR; Cruz Sde S Rev Bras Med; 1969 Jun; 26(6):366-70. PubMed ID: 5350708 [No Abstract] [Full Text] [Related]